IMA vs MRNA · rev $9.2M vs rev $1.94B
ImageneBio, Inc. (IMA) versus Moderna Inc (MRNA) — a side-by-side from cached financials, not a winner call.
ImageneBio, Inc. (IMA) is a biotechnology company listed on NASDAQ.
Moderna Inc (MRNA) is a biotechnology company listed on NASDAQ. It is led by Stephane Bancel.
Latest reported IMA revenue for 2023-12-31 was $9.2M. Net income was -$68.2M. Revenue was down 41.3% from 2022-12-31 to 2023-12-31. IMA currently screens at market cap $64.7M.
Latest reported MRNA revenue for 2025-12-31 was $1.94B. Net income was -$2.82B. Revenue was down 39.9% from 2024-12-31 to 2025-12-31. MRNA currently screens at market cap $24.52B.
IMA currently screens at market cap $64.7M. MRNA currently screens at market cap $24.52B.
Not investment advice. Open the IMA and MRNA stock pages for the full models.
Not investment advice.